Loading…
Loading…
Sonic Healthcare (ASX:SHL), the global pathology and radiology group, faces pressure from US reimbursement cuts. In September 2026, Pendal Group warned of potential 3% to 4% reductions to profit after US regulator CMS published lab fee schedule cuts averaging 16%. Pendal described the FY26 result as one of Sonic's better ones in years, with revenue up 13% but organic growth closer to 5%, and momentum not carrying into FY27. Investors Mutual noted market scepticism toward larger, lower-margin pathology players, while Alliance Bernstein rated it a hold but very interested. Sonic Healthcare operates in the Healthcare sector within the Healthcare Providers and Services industry, and Thesis Tracker has captured 15 comments from 11 fund managers, including Pendal Group, Investors Mutual and Alliance Bernstein. Founded in 1934 and headquartered in Sydney, Sonic provides pathology, radiology and primary care services across Australia, the US, Germany, the UK and Switzerland.
Company figures as of 15 Oct 2026. For information only.
Fund managers including Oracle Advisory Group, Wilson Asset Management, BKI Investment Company, Auscap Asset Management, Infinity Asset Management, Ellerston Capital, Alliance Bernstein, Paradice Investment Management, Ten Cap, Pendal Group and Investors Mutual Limited have invested in Sonic Healthcare Ltd (ASX:SHL).
Alliance Bernstein is interested in Sonic's exposure to preventive diagnostics, and Pendal notes a strong FY26 result and a sale and leaseback of its Brisbane laboratory that frees up capital.
Pendal highlights US lab fee schedule cuts that could reduce profit by 3% to 4% and slowing momentum into FY27, while Investors Mutual notes scepticism about pathology margins.
Sonic Healthcare Ltd. is a Sydney-based medical diagnostics provider established in 1934. The company operates through three primary segments: Laboratory, Radiology, and Other. The Laboratory segment delivers pathology and clinical services. The Radiology segment provides diagnostic imaging services throughout Australia. The Other segment includes medical center operations, occupational health services, and corporate functions. As a leader in medical diagnostics, Sonic Healthcare maintains a diverse portfolio of health services to support patient care and clinical outcomes.
General information only. Thesis Tracker reports what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.
11,356 comments from 164 managers on 761 companies, snapshot 15 Oct 2026.